IUGNF
Imugene Limited

254
Mkt Cap
$60.62M
Volume
3,706.00
52W High
$1.44
52W Low
$0.0101
PE Ratio
-0.91
IUGNF Fundamentals
Price
$0.1886
Prev Close
$0.1767
Open
$0.2173
50D MA
$0.2128
Beta
-6.46
Avg. Volume
7,806.00
EPS (Annual)
-$0.2043
P/B
1.40
Rev/Employee
$0.00
$55.96
Loading...
Loading...

About

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
23

Frequently Asked Questions

What is Market Cap of Imugene Ltd.?
What is the 52-week high for Imugene Ltd.?
What is the 52-week low for Imugene Ltd.?
What is Imugene Ltd. stock price today?
What was Imugene Ltd. stock price yesterday?
What is the PE ratio of Imugene Ltd.?
What is the Price-to-Book ratio of Imugene Ltd.?
What is the 50-day moving average of Imugene Ltd.?
How many employees does Imugene Ltd. have?

Latest IUGNF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.